Core elements of national policy for digital health technology evidence and access.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 39138261.
- Also identified by DOI 10.1038/s41746-024-01209-2 and PMC identifier 11322556.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Digital health technologies (DHT) offer the ability to deliver personalized care, lower barriers to access, and positively impact health outcomes. However, DHT utilization is impacted by insufficient market access pathways. A policy “full-stack”—including regulatory authorization, product value assessment, pricing and reimbursement, and patient access infrastructure—offers a framework for DHT integration into national healthcare ecosystems. Consistent clinical evidence requirements across national jurisdictions will further increase DHT scalability.